Cover Image
市場調查報告書

胰臟癌 :主要17個市場預測 2016-2026年

Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 353109
出版日期 內容資訊 英文 54 Pages
訂單完成後即時交付
價格
Back to Top
胰臟癌 :主要17個市場預測 2016-2026年 Pancreatic Cancer Forecast in 17 Major Markets 2016-2026
出版日期: 2016年02月26日 內容資訊: 英文 54 Pages
簡介

胰臟癌是全球最致命的癌症之一。胰臟癌,是在胰臟的組織上形成的惡性細胞引起。胰臟癌的預後,尤其是後期階段中非常糟糕,在全部的癌症中存活率最低。

本報告提供主要17個市場 (美國、法國、德國、義大利、西班牙、英國、巴西、日本、印度、墨西哥、土耳其、加拿大、澳洲、南非、沙烏地阿拉伯、阿根廷及俄羅斯) 的胰臟癌的目前患者數 (性別,各年齡世代) 調查分析,目前盛行率,加上疾病概要,危險因素,疾病診斷預後,主要的症狀和併發症等系統性資訊

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:各地區/民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化做患者數的手法

胰臟癌的盛行率top line

胰臟癌的階段 (病期) 、位置

  • 胰臟癌的分期
  • 胰臟癌的組織病理
  • 胰臟癌主要的位置

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

價格的線上資料、平台

參考文獻

附錄

目錄
Product Code: PANC0010216

image1

Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of the disease. The prognosis of pancreatic cancer, especially for later stages, is quite poor and has the lowest survival rate of all cancers.

This report provides the current incidence population for Pancreatic Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Canada, Australia, South Africa, Saudi Arabia, Argentina, and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, locations and histopathology of Pancreatic Cancer tumours. These sub-populations within the main disease are included at a country level across a 10-year forecast snapshot.

Main symptoms and co-morbidities for Pancreatic Cancer include:

  • Obesity
  • Diabetes
  • Jaundice
  • Pancreatitis
  • Gallbladder enlargement

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Pancreatic Cancer's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Pancreatic Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Identify sub-populations within Pancreatic Cancer which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Pancreatic Cancer patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, IN, TR, CA, AU, AR, RU, MX, ZA, SA

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions/ Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Incidence for Pancreatic Cancer

Stages and Location of Pancreatic Cancer

  • Staging of Pancreatic Cancer
  • Histopathology of Pancreatic Cancer
  • Pancreatic Cancer Tumour Location

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • AJCC Tumour Staging Classification for Pancreatic Cancer
  • Incidence of Pancreatic Cancer, total (000s)
  • Incidence of Pancreatic Cancer, males (000s)
  • Incidence of Pancreatic Cancer, females (000s)
  • AJCC Stages of Pancreatic Cancer patients, total (000s)
  • Major Histopathological type in Pancreatic Cancer, total (000s)
  • Tumour location in Pancreatic Cancer patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • USA Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • France Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • France Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Germany Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Germany Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Italy Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Italy Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Spain Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Spain Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • UK Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • UK Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Brazil Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Brazil Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Japan Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Japan Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • India Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • India Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Australia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Australia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Canada Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Canada Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Mexico Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Mexico Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Turkey Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Turkey Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • South Africa Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • South Africa Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Saudi Arabia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Saudi Arabia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Argentina Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Argentina Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
  • Russia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
  • Russia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Back to Top